Bodscience
Contact Us Login
Logout
Do you really want to Logout?
  • About Us
    • Our Partners
    • Privacy Policy
    • Terms of Use
  • Research
    • Chronic Pain
    • Anxiety
    • Stress
    • Depression
    • Epilepsy
    • Arthritis
    • Inflammation
  • Investors
    • Investor Centre
    • Investment Highlights
    • ASX Announcements
    • Company Presentations
    • Corporate
    • Your Holdings
    • Media
  • Doctors
    • Doctor Support
    • Clinical Trials and Research
    • Collaboration
    • Our Medical Advisory Board
  • Medical Cannabis
    • How to Access
    • Medical Clinics
    • Find A Doctor
    • FAQ
  • Innovation
    • Aqua Phase
  • Pharmacy Ordering
    • Pharmacy Ordering
  • About Us
    • Our Partners
    • Privacy Policy
    • Terms of Use
  • Research
    • Chronic Pain
    • Anxiety
    • Stress
    • Depression
    • Epilepsy
    • Arthritis
    • Inflammation
  • Investors
    • Investor Centre
    • Investment Highlights
    • ASX Announcements
    • Company Presentations
    • Corporate
    • Your Holdings
    • Media
  • Doctors
    • Doctor Support
    • Clinical Trials and Research
    • Collaboration
    • Our Medical Advisory Board
  • Medical Cannabis
    • How to Access
    • Medical Clinics
    • Find A Doctor
    • FAQ
  • Innovation
    • Aqua Phase
  • Pharmacy Ordering
    • Pharmacy Ordering
Contact Us
  • INVESTORS
  • INVESTOR CENTRE
  • INVESTMENT HIGHLIGHTS
  • ASX ANNOUNCEMENTS
  • COMPANY PRESENTATIONS
  • CORPORATE
  • YOUR HOLDINGS
  • Media
  • Contact details

Media

Bod Science raises £1.9m to ease pressure on R&D costs

03 Aug 2023

Published by: Cannabiz

View article
Study delivers ‘new chapter’ for Bod as Aqua Phase tech shows its worth

26 Jul 2023

Published by: Cannabiz

View article
BOD’s CBD product improves bioavailability by 311%

25 Jul 2023

Published by: Next Investors

View article
ASX Health Stocks: BOD to acquire Aqua Phase on positive data; Bionomics set to delist

25 Jul 2023

Published by: Stockhead

View article
Bod plotting ‘immediate’ overseas move if CBD sleep trial succeeds

19 Jul 2023

Published by: Cannabiz

View article
Bod Completes Trial Of Schedule 3 Cannabidiol Contender

13 Jul 2023

Published by: Hemp Gazette

View article
How Bod Science pulled ahead in the race for Australia’s first over-the-counter CBD

13 Jul 2023

Published by: Stockhead

View article
Bod Science Limited (ASX:BOD) Investor Presentation | July 2023

13 Jul 2023

Published by: Bod Science

View article
Bod Science faces nervy wait as final patient completes S3 clinical trial

10 Jul 2023

Published by: Cannabiz

View article
Phase IIB Insomnia Trial Complete

10 Jul 2023

Published by: Next Investors

View article
❮❮❮1234❯❯❯
Bod Science
  • Privacy Policy
  • Terms of Use
  • Contact us
  • Sitemap

We’d like to use cookies and collect analytics to improve Snips’ websites.
You can find out more in our

Privacy Policy